Nifty
Sensex
:
:
24056.00
77100.47
34.35 (0.14%)
109.25 (0.14%)

Pharmaceuticals & Drugs

Rating :
70/99

BSE: 544067 | NSE: INNOVACAP

941.35
25-Jun-2026
  • Open
  • High
  • Low
  • Previous Close
  •  944.05
  •  980
  •  918
  •  944.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  97974
  •  93079051.7
  •  980
  •  622

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,377.43
  • 38.16
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,716.23
  • 0.21%
  • 4.93

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.90%
  • 1.16%
  • 27.12%
  • FII
  • DII
  • Others
  • 0.23%
  • 11.72%
  • 8.87%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 15.28
  • 14.66

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 19.26
  • 8.44

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 17.12
  • 14.31

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 38.48

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 4.60

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 24.60

Earnings Forecasts:

(Updated: 23-06-2026)
Description
2026
2027
2028
2029
Adj EPS
24.54
33.9
44.5
-
P/E Ratio
38.36
27.77
21.15
-
Revenue
1589.1
1321.5
2427.8
2945
EBITDA
242.4
208
395.95
-
Net Income
140.4
189.75
256.9
327
ROA
-
9.83
11.15
-
P/B Ratio
4.90
4.21
3.50
-
ROE
13.64
16
18.23
-
FCFF
249.98
231.79
124.81
263.13
FCFF Yield
4.43
4.1
2.21
4.66
Net Debt
-
130.8
-3.04
-
BVPS
192.19
223.78
268.67
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
447.80
314.74
42.28%
450.29
316.46
42.29%
380.38
318.20
19.54%
351.54
294.27
19.46%
Expenses
382.71
267.06
43.30%
380.90
269.90
41.13%
328.52
268.47
22.37%
299.44
252.09
18.78%
EBITDA
65.09
47.69
36.49%
69.40
46.56
49.05%
51.86
49.73
4.28%
52.10
42.18
23.52%
EBIDTM
14.54%
15.15%
15.41%
14.71%
13.63%
15.63%
14.82%
14.33%
Other Income
1.56
3.38
-53.85%
1.65
4.33
-61.89%
4.19
2.22
88.74%
4.48
2.12
111.32%
Interest
4.59
1.95
135.38%
3.95
0.17
2,223.53%
5.50
0.15
3,566.67%
2.86
0.14
1,942.86%
Depreciation
11.39
9.80
16.22%
11.42
5.13
122.61%
11.32
4.99
126.85%
11.04
4.85
127.63%
PBT
50.67
39.31
28.90%
55.68
45.59
22.13%
39.23
46.81
-16.19%
42.68
39.31
8.57%
Tax
12.59
9.74
29.26%
13.53
11.38
18.89%
9.57
11.80
-18.90%
11.66
9.83
18.62%
PAT
38.08
29.57
28.78%
42.15
34.20
23.25%
29.67
35.00
-15.23%
31.01
29.48
5.19%
PATM
8.50%
9.40%
9.36%
10.81%
7.80%
11.00%
8.82%
10.02%
EPS
6.66
5.17
28.82%
7.37
5.98
23.24%
5.18
6.12
-15.36%
5.42
5.15
5.24%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
-
1,630.02
1,243.68
1,081.31
926.38
800.53
410.66
373.32
355.81
Net Sales Growth
-
31.06%
15.02%
16.72%
15.72%
94.94%
10.00%
4.92%
 
Cost Of Goods Sold
-
827.16
639.36
579.35
552.63
529.46
273.02
223.68
221.78
Gross Profit
-
802.86
604.32
501.96
373.76
271.07
137.65
149.65
134.02
GP Margin
-
49.25%
48.59%
46.42%
40.35%
33.86%
33.52%
40.09%
37.67%
Total Expenditure
-
1,398.39
1,057.52
926.85
812.73
704.51
356.18
322.39
315.02
Power & Fuel Cost
-
39.12
27.14
20.39
9.51
7.91
5.48
5.54
4.17
% Of Sales
-
2.40%
2.18%
1.89%
1.03%
0.99%
1.33%
1.48%
1.17%
Employee Cost
-
167.20
116.78
90.66
54.80
40.46
22.33
20.24
18.10
% Of Sales
-
10.26%
9.39%
8.38%
5.92%
5.05%
5.44%
5.42%
5.09%
Manufacturing Exp.
-
267.04
207.40
177.68
152.24
100.72
43.28
63.87
62.68
% Of Sales
-
16.38%
16.68%
16.43%
16.43%
12.58%
10.54%
17.11%
17.62%
General & Admin Exp.
-
56.98
36.83
32.63
23.39
15.22
8.59
7.30
6.03
% Of Sales
-
3.50%
2.96%
3.02%
2.52%
1.90%
2.09%
1.96%
1.69%
Selling & Distn. Exp.
-
30.75
18.38
15.67
14.24
6.93
2.18
0.84
0.83
% Of Sales
-
1.89%
1.48%
1.45%
1.54%
0.87%
0.53%
0.23%
0.23%
Miscellaneous Exp.
-
10.14
11.63
10.47
5.93
3.81
1.30
0.93
1.42
% Of Sales
-
0.62%
0.94%
0.97%
0.64%
0.48%
0.32%
0.25%
0.40%
EBITDA
-
231.63
186.16
154.46
113.65
96.02
54.48
50.93
40.79
EBITDA Margin
-
14.21%
14.97%
14.28%
12.27%
11.99%
13.27%
13.64%
11.46%
Other Income
-
18.71
12.04
12.49
9.20
2.88
1.37
1.30
0.22
Interest
-
16.90
2.40
21.46
19.97
5.68
3.93
4.63
5.58
Depreciation
-
45.18
24.78
15.96
11.08
7.50
5.59
10.07
10.67
PBT
-
188.26
171.02
129.53
91.80
85.72
46.34
37.53
24.76
Tax
-
47.35
42.76
35.18
23.84
21.77
11.84
9.64
4.89
Tax Rate
-
25.15%
25.00%
27.16%
25.97%
25.40%
25.55%
25.69%
19.75%
PAT
-
140.92
128.26
94.34
67.95
63.95
34.50
27.89
19.88
PAT before Minority Interest
-
140.92
128.26
94.34
67.95
63.95
34.50
27.89
19.88
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
8.65%
10.31%
8.72%
7.34%
7.99%
8.40%
7.47%
5.59%
PAT Growth
-
9.87%
35.96%
38.84%
6.25%
85.36%
23.70%
40.29%
 
EPS
-
24.64
22.42
16.49
11.88
11.18
6.03
4.88
3.48

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
1,090.79
959.42
830.89
276.51
208.61
144.82
110.35
82.49
Share Capital
57.23
57.23
57.23
48.00
12.00
12.00
12.00
12.00
Total Reserves
1,033.57
902.19
773.67
228.51
196.61
132.82
98.35
70.49
Non-Current Liabilities
250.59
255.75
204.55
194.16
88.09
44.49
14.42
28.20
Secured Loans
214.80
243.55
208.20
62.34
40.36
6.00
11.61
26.35
Unsecured Loans
0.00
0.00
0.00
71.83
26.99
0.00
0.00
0.00
Long Term Provisions
11.92
9.90
9.14
46.82
18.23
36.09
0.56
0.42
Current Liabilities
516.68
376.44
293.98
277.55
315.47
215.15
129.36
117.32
Trade Payables
318.63
201.80
179.66
158.48
144.80
112.23
71.71
61.61
Other Current Liabilities
69.24
77.29
57.98
20.55
28.30
68.96
11.63
10.01
Short Term Borrowings
99.26
65.65
23.84
97.94
120.09
33.43
36.30
40.10
Short Term Provisions
29.55
31.69
32.50
0.58
22.27
0.53
9.71
5.59
Total Liabilities
1,858.06
1,591.61
1,329.42
748.22
612.17
404.46
254.13
228.01
Net Block
841.51
829.87
357.88
182.88
183.03
79.14
73.16
78.50
Gross Block
955.72
901.14
406.39
215.53
205.97
106.64
94.26
89.53
Accumulated Depreciation
114.21
71.27
48.51
32.65
22.93
27.50
21.10
11.03
Non Current Assets
913.00
865.06
721.17
305.75
212.17
134.01
74.00
79.71
Capital Work in Progress
15.50
22.52
340.79
21.54
0.03
7.26
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
16.38
6.82
22.00
101.07
28.82
47.60
0.85
1.22
Other Non Current Assets
39.60
5.85
0.50
0.26
0.28
0.00
0.00
0.00
Current Assets
945.06
719.12
608.25
442.47
400.00
270.46
180.13
148.28
Current Investments
41.28
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
283.26
207.99
144.02
117.32
128.39
91.44
65.49
38.72
Sundry Debtors
437.29
331.64
288.49
265.22
212.69
138.55
86.77
90.83
Cash & Bank
3.87
68.17
86.75
18.88
2.44
11.89
5.18
1.83
Other Current Assets
179.37
33.22
8.91
13.45
56.49
28.57
22.69
16.91
Short Term Loans & Adv.
114.01
78.10
80.08
27.61
50.08
26.05
21.61
15.73
Net Current Assets
428.38
342.69
314.27
164.92
84.53
55.31
50.77
30.97
Total Assets
1,858.06
1,584.18
1,329.42
748.22
612.17
404.47
254.13
227.99

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
116.52
63.84
146.34
67.12
58.90
41.57
PBT
188.26
171.02
129.53
91.80
85.72
46.34
Adjustment
57.64
27.38
37.16
25.92
15.29
9.59
Changes in Working Capital
-103.13
-110.84
7.31
-31.06
-21.27
-1.14
Cash after chg. in Working capital
142.77
87.56
174.00
86.65
79.74
54.80
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-26.25
-23.71
-27.66
-19.53
-20.84
-13.23
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-107.12
-151.59
-498.97
-90.84
-188.12
-19.67
Net Fixed Assets
-42.13
-170.45
-330.93
-31.20
-82.22
Net Investments
-41.28
0.00
0.00
0.00
-60.00
Others
-23.71
18.86
-168.04
-59.64
-45.90
Cash from Financing Activity
-21.71
91.53
360.83
27.09
124.57
-19.34
Net Cash Inflow / Outflow
-12.32
3.79
8.20
3.37
-4.64
2.56
Opening Cash & Equivalents
15.52
11.73
3.52
0.15
4.80
2.23
Closing Cash & Equivalent
3.20
15.52
11.73
3.52
0.15
4.80

Financial Ratios

Standalone /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
190.61
167.66
145.20
57.61
43.46
30.17
ROA
8.17%
8.78%
9.08%
9.99%
12.58%
10.48%
ROE
13.75%
14.33%
17.04%
28.02%
36.19%
27.04%
ROCE
15.04%
14.65%
19.06%
24.34%
30.64%
28.42%
Fixed Asset Turnover
1.79
1.94
3.48
4.46
5.17
4.09
Receivable days
84.59
89.43
93.25
92.78
79.30
100.13
Inventory Days
54.04
50.76
44.01
47.70
49.63
69.74
Payable days
114.83
108.88
106.52
100.16
88.60
122.96
Cash Conversion Cycle
23.80
31.30
30.74
40.32
40.33
46.92
Total Debt/Equity
0.31
0.35
0.29
0.85
0.95
0.31
Interest Cover
12.14
72.11
7.04
5.60
16.09
12.80

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.